Ireland - English - HPRA (Health Products Regulatory Authority)

allergan pharmaceuticals ireland - dipivefrine hydrochloride - eye drops solution - 0.1 %w/v

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - latanoprost -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - latanoprost -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - latanoprost -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - latanoprost -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - latanoprost -

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - latanoprost 0.05 mg/ml - eye drops, solution - 50 mcg/ml - active: latanoprost 0.05 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate monobasic sodium phosphate monohydrate sodium chloride water for injection - indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

alcon laboratories (uk) ltd - dipivefrine hydrochloride - eye drops solution - 0.1 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

allergan pharmaceuticals ireland - dipivefrine hydrochloride pilocarpine hydrochloride - 5 millilitre

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - latanoprost 0.05 mg/ml;  ;   - eye drops, solution - 50 mcg/ml - active: latanoprost 0.05 mg/ml     excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate monobasic sodium phosphate dihydrate purified water sodium chloride - reduction of elevated intraocular pressure in patients with ocular hypertension